Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Thymoma

pyrroles has been researched along with Thymoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (77.78)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Catania, C; Cocorocchio, E; Conforti, F; Corti, C; Curigliano, G; de Pas, T; Ferrucci, PF; Pala, L; Queirolo, P1
Antonarelli, G; Catania, C; Conforti, F; Corti, C; Curigliano, G; De Pas, T; Lo Russo, G; Manglaviti, S; Perrino, M; Salvini, P; Varano, GM; Zucali, PA1
Brzezniak, C; Szabo, E1
Berman, A; Brzezniak, C; Carter, CA; Giaccone, G; Guha, U; Lee, MJ; Lee, S; Ling, A; Loehrer, PJ; Meltzer, P; Rajan, A; Spittler, AJ; Steinberg, SM; Szabo, E; Thomas, A; Tomita, Y; Trepel, JB; Wang, Y1
Marx, A; Weis, CA1
Besse, B; Dansin, E; Dubos, C; Girard, N; Greillier, L; Lindsay, CR; Mazieres, J; Pichon, E; Remon, J1
Bargou, R; Dimitrakopoulou-Strauss, A; Hohenberger, P; Manegold, C; Marx, A; Mayer, F; Sauer, C; Spitzer, D; Strauss, L; Ströbel, P; Wolff, A1
Buti, S; Buttitta, F; Calabrese, F; Cavazza, A; Di Chiara, F; Felicioni, L; Garagnani, L; Marchetti, A; Mengoli, MC; Migaldi, M; Nannini, N; Nicoli, D; Rea, F; Rossi, G; Sartori, G; Schirosi, L; Valli, R1
Buti, S; Donini, M; Passalacqua, R; Rossi, G; Rossi, V; Sergio, P1

Trials

1 trial(s) available for pyrroles and Thymoma

ArticleYear
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
    The Lancet. Oncology, 2015, Volume: 16, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Indoles; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Pyrroles; Sunitinib; Survival Rate; Thymoma; Thymus Neoplasms

2015

Other Studies

8 other study(ies) available for pyrroles and Thymoma

ArticleYear
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 172

    Topics: Antineoplastic Agents; Compassionate Use Trials; Exons; Gastrointestinal Stromal Tumors; Humans; Melanoma; Mutation; Precision Medicine; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrroles; Thymoma; Thymus Neoplasms; Triazines

2022
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 174

    Topics: Humans; Indoles; Neoplasms, Glandular and Epithelial; Platinum; Pyrroles; Retrospective Studies; Sunitinib; Thymoma; Thymus Neoplasms; Treatment Outcome

2022
Images in clinical medicine. Sunitinib-associated hair depigmentation.
    The New England journal of medicine, 2014, Apr-24, Volume: 370, Issue:17

    Topics: Adult; Antineoplastic Agents; Female; Hair; Humans; Indoles; Pigmentation Disorders; Pyrroles; Sunitinib; Thymoma; Thymus Neoplasms

2014
Sunitinib in thymic carcinoma: enigmas still unresolved.
    The Lancet. Oncology, 2015, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Indoles; Male; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pyrroles; Sunitinib; Thymoma; Thymus Neoplasms

2015
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network.
    Lung cancer (Amsterdam, Netherlands), 2016, Volume: 97

    Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Clinical Trials, Phase II as Topic; Disease-Free Survival; Female; Humans; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrroles; Retrospective Studies; Sunitinib; Thymoma; Thymus Neoplasms; Treatment Outcome; Young Adult

2016
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience.
    British journal of cancer, 2010, Jul-13, Volume: 103, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Indoles; Male; Mutation; Neoplasm Metastasis; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Sunitinib; Thymoma; Thymus Neoplasms

2010
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Benzenesulfonates; Carcinoid Tumor; Carcinoma, Squamous Cell; CD5 Antigens; DNA Mutational Analysis; Enzyme Activation; Female; Genetic Association Studies; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Mutation, Missense; Niacinamide; Phenylurea Compounds; Piperazines; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Retrospective Studies; Sorafenib; Sunitinib; Thymoma; Thymus Neoplasms; Transcription Factors; Treatment Outcome; Tumor Suppressor Proteins

2012
When a thymic carcinoma "becomes" a GIST.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 80, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Mutation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sunitinib; Thymoma; Thymus Neoplasms; Treatment Failure; Treatment Outcome

2013